Supernus Pharmaceuticals Inc Capital Reinvestment Ratio
Supernus Pharmaceuticals Inc capital reinvestment ratio. Supernus Pharmaceuticals Inc (SUPN) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($19.86 Million) in capital expenditures ($427.00K). See Supernus Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Supernus Pharmaceuticals Inc (2009–2025)
Capital reinvestment ratio of Supernus Pharmaceuticals Inc from 2009 to 2025. This chart tracks Supernus Pharmaceuticals Inc's Capital Reinvestment Ratio across 13 annual periods. See SUPN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Supernus Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2009–2025)
Supernus Pharmaceuticals Inc capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Supernus Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $47.33 Million | $1.34 Million | ▲ +570.5% |
| 2024 | 0.00x | $171.95 Million | $725.00K | ▼ -15.0% |
| 2023 | 0.00x | $111.08 Million | $551.00K | ▲ +40.6% |
| 2022 | 0.00x | $116.83 Million | $412.00K | ▼ -78.1% |
| 2021 | 0.02x | $127.13 Million | $2.04 Million | ▼ -35.5% |
| 2020 | 0.02x | $138.40 Million | $3.45 Million | ▲ +30.4% |
| 2019 | 0.02x | $143.13 Million | $2.74 Million | ▲ +192.1% |
| 2018 | 0.01x | $128.99 Million | $844.00K | ▼ -63.0% |
| 2017 | 0.02x | $114.64 Million | $2.03 Million | ▼ -26.2% |
| 2016 | 0.02x | $66.81 Million | $1.60 Million | ▼ -63.4% |
| 2015 | 0.07x | $32.12 Million | $2.10 Million | ▼ -14.6% |
| 2014 | 0.08x | $7.73 Million | $593.00K | ▼ -71.7% |
| 2009 | 0.27x | $2.63 Million | $714.00K | — |